Introduction
Although disseminated intravascular coagulation (DIC) is an “intermediary mechanism
of disease”1 that has been intensively studied during the last three decades,2-4 several aspects relating to the clinical problem of DIC are still under debate. For
example, a standardized definition of disseminated intravascular coagulation has not
yet been agreed upon. A diagnosis can be accurately made using the facilities of a
specialized laboratory, but time constraints make the diagnosis of DIC by the general
laboratory difficult. Since DIC can be prevented if the right therapy is initiated
early, the ability to quickly and accurately diagnose DIC and to monitor the involved
dynamic processes are essential prerequisites for the effective management patients
with DIC.
Due to the problems associated with defining DIC, making an early diagnosis, and effectively
treating the condition following diagnosis, the clinical management of DIC can be
difficult. The transition from an activated hemostatic system to a well-defined state
of DIC is indistinct, and the borderlines cannot easily be distinguished. In addition,
different underlying diseases mediating DIC induce different clinical symptoms associated
with DIC and demand different therapeutic approaches.
